Tooth-Derived graft may boost jaw bone healing after cyst removal

NCT ID NCT07652216

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using a patient's own tooth-derived bone graft (ADDM) combined with a platelet-rich fibrin (A-PRF) can improve bone healing after removing a dentigerous cyst and an impacted wisdom tooth. Thirty-five adults with this condition will receive either standard care (blood clot), A-PRF alone, or A-PRF plus ADDM. The main goal is to measure bone defect reduction on CT scans at 6 and 12 months, with pain as a secondary outcome.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Autogenous Demineralized Dentin Matrix (ADDM) and Advanced Platelet-Rich Fibrin (A-PRF)
What this could lead to
If successful, this approach could speed up bone regeneration and reduce pain after jaw cyst surgery, offering a better recovery option.
What could go wrong
This is a small, early-stage study with only 35 participants, so results may not apply to everyone. The treatments are experimental and may not improve healing over natural blood clot formation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOGENOUS DENTIN GRAFT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Oral Surgery, Institute of Dentistry, Jagiellonian University Medical College

    Krakow, Malopolska, 31-155, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.